iSpecimen Inc. 8-K

What Happened
iSpecimen Inc. announced in a press release dated April 9, 2026 that it has achieved an 85% reduction in human biospecimen shipping time. The company filed a Form 8-K on April 10, 2026 under Item 7.01 (Regulation FD Disclosure) to report the press release.

Key Details

• 85% reduction reported in human biospecimen shipping time (press release dated April 9, 2026).
• Press release attached to the 8-K as Exhibit 99.1.
• Form 8-K filed April 10, 2026 under Item 7.01 (Regulation FD Disclosure).
• The filing does not include earnings, revenue figures, or forward financial guidance.

Why It Matters
This is an operational update indicating a significant improvement in the company’s specimen logistics. Because the 8-K is a Regulation FD disclosure, it provides material operational information but does not present financial results; investors should watch for subsequent filings or disclosures that quantify any impact on revenue, costs, or margins.